Lin, S., Lin, J., Hsueh, C., Chou, T., & Wong, R. J. (2017). A cyclin-dependent kinase inhibitor, dinaciclib in preclinical treatment models of thyroid cancer. PLoS One.
Chicago Style aipamenaLin, Shu-Fu, Jen-Der Lin, Chuen Hsueh, Ting-Chao Chou, and Richard J. Wong. "A Cyclin-dependent Kinase Inhibitor, Dinaciclib in Preclinical Treatment Models of Thyroid Cancer." PLoS One 2017.
MLA aipamenaLin, Shu-Fu, et al. "A Cyclin-dependent Kinase Inhibitor, Dinaciclib in Preclinical Treatment Models of Thyroid Cancer." PLoS One 2017.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.